Killer Cells

Natural killer cells express inhibitory receptors specific for mhc class i proteins and stimulatory receptors with diverse specificities. Here is the latest research on natural killer cells.

January 16, 2022

Prognostic implication of CTLA-4, PD-1, and PD-L1 expression in aggressive adult T-cell leukemia-lymphoma.

Annals of Hematology
Akio OnishiTakahiro Fukuda
January 16, 2022

Systematic Determination of TCR-Antigen and Peptide-MHC Binding Kinetics among Field Variants of a Theileria parva Polymorphic CTL Epitope.

The Journal of Immunology : Official Journal of the American Association of Immunologists
Nicholas SvitekLucilla Steinaa
January 16, 2022

Long-acting recombinant human interleukin-7, NT-I7, increases cytotoxic CD8+ T cells and enhances survival in mouse glioma models.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Jian L CampianDinesh Thotala
January 16, 2022

Codelivery of Shikonin and siTGF-β for enhanced triple negative breast cancer chemo-immunotherapy.

Journal of Controlled Release : Official Journal of the Controlled Release Society
Ji LiDongkai Wang
January 16, 2022
Open Access

Cancer exosomes and natural killer cells dysfunction: biological roles, clinical significance and implications for immunotherapy.

Molecular Cancer
Reza HosseiniNahid Eskandari
January 16, 2022

The frequencies of peripheral blood CD5+CD19+ B cells, CD3-CD16+CD56+ NK, and CD3+CD56+ NKT cells and serum interleukin-10 in patients with multiple sclerosis and neuromyelitis optica spectrum disorder.

Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
Leila KhaniGordon A Ferns
January 15, 2022

PDGF-D-PDGFRβ signaling enhances IL-15-mediated human natural killer cell survival.

Proceedings of the National Academy of Sciences of the United States of America
Shoubao MaJianhua Yu
January 15, 2022

Daily briefing: 'Killer' T cells still recognize Omicron.

Flora Graham
January 15, 2022
Open Access

Control of Tumors by Antigen-Specific CD8+ T Cells through PDL1-Targeted Delivery of Antigenic Peptide.

Journal of Immunology Research
Po-Hao FengChien-Fu Hung
January 15, 2022

Olfactory function in congenital cytomegalovirus infection: a prospective study.

European Journal of Pediatrics
Françoise LazariniNatacha Teissier
January 14, 2022

Osteoblastoma of the Rib Mimicking Lymphomatous Involvement on 18F-FDG PET/CT Imaging.

Clinical Nuclear Medicine
Pan TangGuocai Yang
January 14, 2022
Open Access

Itaconate and derivatives reduce interferon responses and inflammation in influenza A virus infection.

PLoS Pathogens
Aaqib SohailFrank Pessler
January 14, 2022

Unique symbiont-derived sphingolipids: Dietary amino acids source branch formation.

Cell Host & Microbe
Yoshiyuki Goto
January 14, 2022

Changes in CD163+, CD11b+, and CCR2+ peripheral monocytes relate to Parkinson's disease and cognition.

Brain, Behavior, and Immunity
Sara Konstantin NissenMarina Romero-Ramos
January 14, 2022

Interleukin-12 as an in situ cancer vaccine component: a review.

Cancer Immunology, Immunotherapy : CII
Emily M ChengAlexander L Rakhmilevich

Sign up to follow this feed and discover related papers.

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.


Basophils are myeloid cells with a high affinity IgE receptor and is involved in inflammatory responses during allergy. Discover the latest research on Basophils here.

Classical Complement Pathway

The Classical Complement Pathway is activated by antigen-antibody complexes. Activation of this pathway leads to the generation of the membrane attack complex, which kills pathogenic cells. Discover the latest research on the Classical Complement Pathway here.

Complement Pathway: Mannose-Binding Lectin

The Mannose-Binding Lectin Complement Pathway is activated when mannose-binding lectin binds to mannose found on the surface of pathogens. Subsequent complement activation is similar to the classical complement pathway, but without the need for antigen-antibody complexes. Discover the latest research here.

Inflammation Mediators

Inflammation Mediators include cytokines, prostaglandins and other molecules that ochestrate the inflammatory process in response to injury, allergy or pathogens. Discover the latest research on Inflammation Mediators here.

Innate Immunity and CNS

Innate immune responses in the CNS are carried out by microglia and astrocytes. Here is the latest research on mechanisms underlying innate immunity in the CNS and its impact on neurophysiology.

Innate Immunity in Lower Organisms

Many components of the mammalian innate immune system have homologs in lower organisms, such as invertebrates. Discover the latest research on Innate Immunity in Lower Organisms here.

Innate Immunity: Neurodegeneration

The innate immune system is a first line of defense against infection. Pathological states can occur if there is over activation of the innate immune system, particularly in the brain. The excessive activation of these cells can lead to inflammation and neurodegenerative diseases. Here is the latest research on innate immunity and neurodegeneration.

Intracellular Killing

Intracellular killing involves the death of microbes within the phagocyte. Here is the latest research on intracellular killing.

© 2022 Meta ULC. All rights reserved